Kathy Borelli · Member of Parliament, House of Commons
Mary Coyle · Senator, Senate of Canada
Kim Pate · Senator, Senate of Canada
Mohamed-Iqbal Ravalia · Senator, Senate of Canada
Joan Kingston · Senator, House of Commons
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).Read more
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
Margaret Dawn Anderson · Senator, Senate of Canada
Pat Duncan · Senator, Senate of Canada
Jessica Fancy- Landry · Member of Parliament, House of Commons
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilitiesRead more
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).
Amen Ben Ahmouda · Policy advisor, House of Commons
Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilitiesRead more
Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of poverty
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).Read more
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
Wayne Long · Secretary of State, Canada Revenue Agency (CRA)
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).Read more
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).Read more
Canada Health Act and regulations, as it relates to long-term and home care
CIHR as it relates to federal funding & long term investment in health research
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilitiesRead more
Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of poverty
Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities
CIHR as it relates to federal funding & long term investment in health research
Kevin Murphy · Director, Employment and Social Development Canada (ESDC)
Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of povertyRead more
CIHR as it relates to federal funding & long term investment in health research
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
Jason Easton · Strategic Advisor Special Projects, Prime Minister's Office (PMO)
Mike Morrice · Member of Parliament, House of Commons
Bonita Zarrillo · Member of Parliament, House of Commons
Kamal Khera · Minister of Seniors, Employment and Social Development Canada (ESDC)
Ophelia John · Special Assistant Policy, Health Canada (HC)
Mark Holland · Minister of Health, Health Canada (HC)
Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of povertyRead more
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
Tracy Gray · Member of Parliament, House of Commons
Aaron Wudrick · Director of Policy, House of Commons
Andrew Evans · Policy Advisor, House of Commons
Peter Julian · Member of Parliament, House of Commons
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.Read more
Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of poverty
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).
Eshan Naik · Director of Policy, Health Canada (HC)
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).Read more
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
CIHR as it relates to federal funding & long term investment in health research
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.